Live Breaking News & Updates on Industrial Affairs At Valbiotis

Stay updated with breaking news from Industrial affairs at valbiotis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Valbiotis announces that it has received Food and Drug Administration (FDA) approval for New Dietary Ingredient (NDI) status

VALBIOTIS SA

Valbiotis announces that it has received Food and Drug Administration approval for New Dietary Ingredient status 11-Dec-2023 / 20:02 CET/CEST

Dissemination of a French. ....

Seitosei Actifin , Young Innovative Company , Industrial Affairs At Valbiotis , European Union , Public Affairs , European Regional Development Fund , Health Science , Drug Administration , Innovative Company , French Financial Markets Authority , New Dietary Ingredient , Executive Committee , Industrial Affairs , Quebec City , Valbioti Universal Registration Document ,

Valbiotis Announces Approval to Launch the Two Phase II/III INSIGHT and INSIGHT 2 Clinical Studies, the Last Step in the Development of TOTUM•854 For the Reduction of Blood Pressure

These authorizations enable the simultaneous launch of recruitment for these international studies, which should be completed in the first half of 2023. The INSIGHT and INSIGHT 2 randomized ....

United States , European Regional Development Fund , Young Innovative Company , Industrial Affairs At Valbiotis , European Union , Research Development , Innovative Company , Industrial Affairs , Quebec City , Valbiotis Universal Registration Document , French Financial Markets Regulator ,

Valbiotis Announces That It Has Submitted to the Competent Authorities the Three Clinical Protocols for TOTUM•854 Indicated in the Reduction of Blood Pressure and Presents Its Comprehensive Clinical Development Plan

The INSIGHT international, multicenter, randomized, placebo-controlled pivotal Phase II/III clinical study will be conducted with a 3.7 g/day dose of TOTUM•854 on 400 volunteers; The INSIGHT ....

United States , France General , United Kingdom , Carole Rocher Marc Delaunay , European Regional Development Fund , European Society Of Hypertension , World Health Organization , International Society Of Hypertension , University Of Avignon , Research Development , Young Innovative Company , Industrial Affairs At Valbiotis , European Union , Ecology Lab La , Innovative Company , European Society , International Society , Industrial Affairs , Chief Operating Marketing , Business Officer , Cardiovascular Pharm Ecology Lab , Quebec City , Valbiotis Universal Registration Document , French Financial Markets Regulator , Rocher Marc Delaunay ,